Celebrating our 10th anniversary – Unlock our special offer today
LATEST ALERTS
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.
As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in violation of the Food Drug & Cosmetics (FD&C) Act. But the other two represented something different. For one, they came from a new FDA » Continue Reading.
There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.
The CEO of one company targeted by the US Federal Trade Commission (FTC) in the first ever group of fines handed down by the government agency to CBD companies considers the event to be a David and Goliath victory of sorts
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.
Cannabis giant Canopy Growth has defended its decision to use a celebrity astrologer to promote the US launch of its CBD-infused sparkling water drink Quatreau
UK white label CBD company Taylor Mammon has been acquired by US hemp firm GenCanna
British American Tobacco (BAT) has continued its expansion into the cannabinoid space by signing a research collaboration agreement with Organigram, a licensed Canadian cannabis producer
There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.
As the UK’s deadline for novel food applications looms, many firms are upbeat about the prospects for CBD businesses in Northern Ireland, but almost all those CBD-Intel spoke to expressed frustration at a lack of clarity
CBD-Intel podcasts editor Jon Bruford is joined by the founder and principal of Kight Law Office, Rod Kight, a specialist in cannabis business law in the US
The heir to the Wrigley’s chewing gum fortune, Beau Wrigley, has entered into a deal he claims will accelerate the growth of his multi-state cannabis company, Parallel, and change the landscape of the US cannabis market
Canadian cannabis brand Hexo has acquired medical and recreational cannabis producer Zenabis Global in a CAD 235m deal that will boost its cultivation capacity and secure a footprint in the European market
Charlotte’s Web has signalled that it believes the US will legalise cannabis at the federal level within three years through a deal to acquire a related THC business
Investing in the medical cannabis and CBD space in the UK is only likely to continue as companies are now legally allowed to list on Europe’s biggest stock exchange, while demand by retail investors continues to spur interest
The FSA has confirmed to CBD-Intel that it has already validated at least one application with an updated list to be published in April. This represents a significantly quicker turnaround than many anticipated, though Pureis did submit its application as soon as possible – telling CBD-Intel that it filed it one minute after midnight on 1st January 2021. However assuming » Continue Reading.
There is a chance that enforcement priorities could change under new appointments to the Federal Trade Commission (FTC) by the Biden administration. Two commissioners – one of which is staying on to work as part of the Republican minority of the five-commissioner panel in charge of the FTC, and the other of which appears to have some influence on their likely » Continue Reading.
CBD-infused gin manufacturer Silent Pool remains defiant after drinks industry regulatory body the Portman Group ruled that its Colorado High product was in violation of its code
British American Tobacco (BAT) is looking “beyond nicotine” to alternative sources of revenue, and has described CBD as an “exciting growth area for our business for the future”
Jon Bruford, CBD-Intel’s podcasts editor, is joined by the CEO & co-founder of the Greenheart CBD Ltd, Mark Canavan, an Irish-owned company that produces and sells CBD oil made from Irish-grown hemp
The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable THC levels in CBD consumer products. The ACMD has not yet responded and the previous limit of 1 mg generic tolerance for » Continue Reading.
Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel junior legal analyst Elsa Carrasco, who discusses the current regulatory framework in place for CBD and cannabis in the Philippines. Elsa presents a clear idea of the legal framework of the country, the requirements to operate in the CBD industry in » Continue Reading.
The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved in other jurisdictions any differently during its own assessment process. But beyond that, it has not stated what other influence the FSA » Continue Reading.
The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing out further guidance for producers of CBD alcoholic beverages – the first time it will have addressed the issue. So it is important to » Continue Reading.
GW Pharmaceuticals, the British manufacturer of the CBD-based epilepsy drug Epidiolex, has been acquired by Jazz Pharmaceuticals in a cash and shares deal worth over $7bn
Specific UK guidance for producers of drinks containing both alcohol and CBD will be developed after the first complaint against one such brand was upheld by the voluntary regulating body for the UK drinks industry
The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.
Pyxus International, a major supplier of products to the tobacco and vaping sectors, is to sell off its cannabis-related business while restructuring its industrial hemp and CBD operations
British CBD brands are suspending shipping to the EU, European customers are hit by unexpected import fees, and UK entrepreneurs are struggling to establish their start-ups, as Brexit regulations cause chaos
Texas-based Collective Growth is remaining positive despite failing to find the right partners for a $150m investment fund raised to develop the US hemp market
Renewed interest in financing of CBD and cannabis businesses could signal that investors are starting to be positive again about the future after companies seemingly weathered the worst of the storm in 2020
Dutch officials have granted a six-month reprieve to find a solution to an omission in the Brexit negotiations that threatens to deprive British epilepsy patients of access to cannabis-based medicines
The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango and berry – and two strengths – 50 mg at £9.99 and 100 mg at £14.99) would be priced at the higher end of » Continue Reading.
The National Credit Union Association (NCUA) has highlighted serving the hemp industry as a priority for 2021, which may enable more hemp businesses to access banking and financial services
Health and wellness appear to be the primary marketing position for new cannabinoid beverage launches
Big Tobacco has entered the CBD sector with British American Tobacco (BAT) launching a CBD e-liquid cartridge compatible with its Vuse vaping device
Molson Coors and Hexo joint-venture Truss has finally released its CBD beverage in the US state of Colorado.
Canopy Growth has sued GW Pharmaceuticals over patent infringement in a case that could have wider-spread consequences for the CBD industry
Marketers recommend the use of gift cards, along with discounts on higher strength and quality blends to drive new consumer growth in January and to convert new customers into repeat customers
Canadian cannabis firms Aphria and Tilray have announced a merger that will create “the world’s largest weed company”, operating under the Tilray name
Claims that CBD could help shrink tumours were among those censured by the US Food and Drug Administration (FDA) in its latest round of warning letters to the industry
Increasing numbers of celebrities are endorsing CBD products, with names as big as will.i.am, Jay-Z, Beyoncé and Gwyneth Paltrow among those investing or launching their own brands
The first ever fines – ranging up to $85,000 – have been issued to CBD companies by the US Federal Trade Commission (FTC) for deceptive marketing practices
It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black Friday at the end of November into the gift-giving Christmas and other holidays period through December. Overall, the market is still too » Continue Reading.
Californian “cellular agriculture company” Cellibre has closed a round of funding that will enable it to accelerate the production of pharmaceutical-grade cannabinoids via fermentation
Another company has been warned by the US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) to stop claiming CBD can cure or mitigate the symptoms of COVID-19
The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a baseline level of requirements and » Continue Reading.
While solid research explaining the science behind CBD remains lacking as the market continues to grow, some bad actors in the industry are making false scientific claims for their products
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
